U.S. Markets open in 8 hrs 7 mins

Synthetic Biologics Inc. (SYN) in Focus: Stock up 9.5%

Zacks Equity Research

Synthetic Biologics Inc. (SYN) was a big mover last session, as the company saw its shares rise over 9% on the day. This rally higher can be attributable to solid volume too with far more shares changing hands than in a normal session. This continues the most recent uptrend of the company, as the stock is now up 26.84% in the past one-month time frame.

In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged. However, yesterday’s price action is encouraging, so make sure to keep a close watch on this firm in the near future.

Synthetic Biologics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some other players in the healthcare industry include Alexion Pharmaceuticals, Inc. (ALXN), with a Zacks Rank #1 (Strong Buy) along with Actelion Ltd. (ALIOF) and Cambrex Corporation.(CBM) holding a Zacks Rank #2 (Buy).  

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

SYNTHETIC BIOLOGICS INC (SYN): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report


CAMBREX CORP (CBM): Free Stock Analysis Report

Zacks Investment Research